MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s00774-024-01563-x

Медицинская библиотека · Journal of bone and mineral metabolism · 2024

Meclozine and growth hormone ameliorate bone length and quality in experimental models of achondroplasia.

Sawamura Kenta, Matsushita Masaki, Esaki Ryusaku, Mishima Kenichi, Kamiya Yasunari, Ohno Kinji, Kitoh Hiroshi, Imagama Shiro

СтатьяПеревод в очереди

Аннотация

INTRODUCTION

Achondroplasia (ACH) is a common skeletal dysplasia associated with short-limbed short stature caused by gain-of-function mutations in the fibroblast growth factor receptor 3 (FGFR3) gene. Meclozine was found to inhibit FGFR3 signaling using a drug repositioning strategy. In some countries, growth hormone (GH) has been employed to ameliorate short stature in children with ACH. This study aims to investigate the effects of meclozine and GH on bone growth and quality using an experimental model of ACH.

MATERIALS AND

METHODS

Meclozine (2 mg/kg/day) and/or GH (0.35 mg/kg/day) were administered to a mouse model of ACH from the age of 7 to 56 days. Body length and body weight of each mouse were measured during these treatments. At the end of treatments, these mice were subjected to micro-computed tomography scans to measure the lengths of long bones and bone mineral density (BMD). The width of the growth plate was quantified by histological analysis.

RESULTS

The body and bone length of transgenic mice significantly increased after treatment with meclozine and GH, although there was no additive effect of the combination therapy on promoting bone growth. In contrast, BMD was additively increased by the combination therapy. The width of the growth plate in transgenic mice was significantly increased by both treatments, although the hypertrophic zone was enlarged by meclozine but not by GH.

CONCLUSION

Meclozine or GH may be an option for treating children with ACH to ameliorate bone length and quality, but the additive effect would be limited.

Для цитирования: Sawamura Kenta, Matsushita Masaki, Esaki Ryusaku, Mishima Kenichi, Kamiya Yasunari, Ohno Kinji, Kitoh Hiroshi, Imagama Shiro. Meclozine and growth hormone ameliorate bone length and quality in experimental models of achondroplasia.. Journal of bone and mineral metabolism. 2024. DOI: 10.1007/s00774-024-01563-x.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.